Published in Surg Clin North Am on August 01, 2010
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One (2012) 1.11
Radical irradiation of extracranial oligometastases. J Clin Oncol (2014) 1.07
Caudate lobe resections: a single-center experience and evaluation of factors predictive of outcomes. World J Surg Oncol (2013) 0.76
Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients. Int J Clin Oncol (2012) 0.75
Intermittent clamping of the hepatic pedicle in simultaneous ultrasonography-guided liver resection and colorectal resection with intestinal anastomosis: is it safe? Int J Colorectal Dis (2014) 0.75
Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis. Int J Clin Oncol (2015) 0.75
Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg (2008) 2.80
Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol (2004) 2.18
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg (2014) 2.15
Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol (2012) 1.99
Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol (2008) 1.88
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol (2006) 1.85
A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg (2010) 1.83
Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg (2004) 1.58
Nutritional management during neoadjuvant therapy for esophageal cancer. J Surg Oncol (2009) 1.54
Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer (2010) 1.53
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol (2011) 1.48
Assessment of mitotic rate reporting in melanoma. Am J Surg (2012) 1.47
The lower incidence of melanoma in women may be related to increased preventative behaviors. Am J Surg (2010) 1.45
Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg (2014) 1.44
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol (2009) 1.44
An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg (2009) 1.42
Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in kentucky. Breast J (2005) 1.41
Factors associated with surgical options for breast carcinoma. Cancer (2006) 1.34
Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB (Oxford) (2007) 1.33
Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One (2013) 1.32
Gender-related differences in outcome for melanoma patients. Ann Surg (2006) 1.32
Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg (2004) 1.25
Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol (2008) 1.20
Surgical management of pulmonary carcinoid tumors: sublobar resection versus lobectomy. Am J Surg (2012) 1.20
Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg (2008) 1.18
Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol (2009) 1.10
A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients. Surgery (2008) 1.08
Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol (2009) 1.08
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res (2009) 1.06
A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med (2012) 1.03
Stroke volume variation in hepatic resection: a replacement for standard central venous pressure monitoring. Ann Surg Oncol (2013) 1.02
Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus (2007) 1.01
Popliteal lymph node dissection. Ann Surg Oncol (2005) 1.00
Laparoscopic versus open resection of hepatic colorectal metastases. Surgery (2012) 1.00
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? J Am Coll Surg (2009) 0.99
Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg (2011) 0.99
Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling. Ann Surg Oncol (2013) 0.98
Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol (2010) 0.98
Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol (2006) 0.98
Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford) (2012) 0.98
A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg (2008) 0.98
The evolving importance of readmission data to the practicing surgeon. J Am Coll Surg (2010) 0.97
Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study. HPB (Oxford) (2010) 0.97
Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg (2010) 0.96
Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis. Ann Surg Oncol (2008) 0.96
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll Surg (2009) 0.94
Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Arch Surg (2005) 0.92
Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg (2011) 0.92
Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma. World J Gastroenterol (2006) 0.92
Second primary melanomas: incidence and outcome. Am Surg (2010) 0.92
Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med (2011) 0.92
Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer (2002) 0.91
Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg (2011) 0.90
Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J (2007) 0.90
Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol (2007) 0.89
Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol (2011) 0.89
The prognostic significance of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol (2010) 0.88
Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg (2008) 0.88
Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World J Surg (2006) 0.88
recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Ann Surg Oncol (2011) 0.87
Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature. Am Surg (2008) 0.87
A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol (2008) 0.87
Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann Surg Oncol (2010) 0.87
Are 3 sentinel nodes sufficient? Arch Surg (2007) 0.86
Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg (2013) 0.86
Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Am Surg (2011) 0.86
Loss of manganese superoxide dismutase expression and activity in rat esophagus with external esophageal perfusion. Surgery (2007) 0.86
Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma. Ann Surg Oncol (2007) 0.86
Lymphovascular invasion as a prognostic factor in melanoma. Am Surg (2011) 0.86
Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg (2008) 0.85
Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma? Am J Surg (2010) 0.85
Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann Surg Oncol (2007) 0.85
Hepatic tumor ablation: cryo versus radiofrequency, which is better? Am Surg (2006) 0.84
Body mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg (2007) 0.84
Low-energy DC current ablation in a mouse tumor model. Methods Mol Biol (2014) 0.84
Effect of multiple-nodal basin drainage on cutaneous melanoma. Arch Surg (2008) 0.84
Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg (2010) 0.84
A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg (2011) 0.84
Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol (2011) 0.84
Impact of histology on survival in retroperitoneal sarcomas. Am J Surg (2011) 0.83
Transarterial chemoembolization and selective internal radiation for the treatment of patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost. Oncologist (2011) 0.83
Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg (2005) 0.83
Esophageal injury with external esophageal perfusion. J Surg Res (2005) 0.83
Surgeon and community factors affecting breast cancer sentinel lymph node biopsy. Am J Surg (2005) 0.83
Differences between bipolar compression and ultrasonic devices for parenchymal transection during laparoscopic liver resection. HPB (Oxford) (2012) 0.83
Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? HPB (Oxford) (2010) 0.83
Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers? Nat Clin Pract Oncol (2005) 0.83
Clinicopathologic and survival differences between upper and lower extremity melanomas. Am Surg (2012) 0.82
Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer. J Surg Oncol (2013) 0.82
Ablative therapies for colorectal liver metastases. Surg Oncol Clin N Am (2010) 0.82
Unique prognostic factors in acral lentiginous melanoma. Am J Surg (2012) 0.82
Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinoma. Int J Nanomedicine (2013) 0.81
Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids. World J Gastroenterol (2010) 0.81
Endoscopic therapy for Barrett's esophagus: a review of its emerging role in optimal diagnosis and endoluminal therapy. Ann Surg Oncol (2011) 0.81
Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation? Ann Surg Oncol (2009) 0.81
Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation. Anticancer Drugs (2009) 0.81
Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg (2006) 0.80